dextroamphetamine has been researched along with Atherosclerotic Parkinsonism in 13 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cansev, M | 1 |
| Ulus, IH | 1 |
| Wang, L | 1 |
| Maher, TJ | 1 |
| Wurtman, RJ | 1 |
| Ramos-Moreno, T | 1 |
| Castillo, CG | 1 |
| Martínez-Serrano, A | 1 |
| Bhattacharjee, AK | 1 |
| Meister, LM | 1 |
| Chang, L | 1 |
| Bazinet, RP | 1 |
| White, L | 1 |
| Rapoport, SI | 1 |
| Miklyaeva, EI | 1 |
| Whishaw, IQ | 1 |
| Kolb, B | 1 |
| Nikkhah, G | 1 |
| Duan, WM | 1 |
| Knappe, U | 1 |
| Jödicke, A | 1 |
| Björklund, A | 1 |
| Pavón, N | 1 |
| Vidal, L | 1 |
| Alvarez, P | 1 |
| Blanco, L | 1 |
| Torres, A | 1 |
| Rodríguez, A | 1 |
| Macías, R | 1 |
| Johnston, RE | 1 |
| Becker, JB | 1 |
| Diamond, BI | 2 |
| Borison, RL | 2 |
| Trabucchi, M | 1 |
| Albizzati, MG | 1 |
| Frattola, L | 1 |
| Scarlato, G | 1 |
| Klawans, HL | 1 |
| Paulson, GW | 1 |
| Dandiya, PC | 1 |
| Bhargava, LP | 1 |
1 review available for dextroamphetamine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
The pharmacology of parkinsonism (a review).
Topics: Acetylcholine; Animals; Atropa belladonna; Atropine; Central Nervous System; Chlorpromazine; Dextroa | 1968 |
12 other studies available for dextroamphetamine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease.
Topics: Animals; Central Nervous System Stimulants; Corpus Striatum; Dextroamphetamine; Docosahexaenoic Acid | 2008 |
Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).
Topics: Animals; bcl-X Protein; Behavior, Animal; Cell Line; Cell Survival; Cells, Cultured; Central Nervous | 2012 |
In vivo imaging of disturbed pre- and post-synaptic dopaminergic signaling via arachidonic acid in a rat model of Parkinson's disease.
Topics: Algorithms; Animals; Arachidonic Acid; Autoradiography; Blood Pressure; Body Temperature; Dextroamph | 2007 |
A golgi analysis of cortical pyramidal cells in the unilateral parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere.
Topics: Animals; Apomorphine; Cerebral Cortex; Dendrites; Dendritic Spines; Dextroamphetamine; Female; Forel | 2007 |
Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; | 1993 |
[Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Dextroamphetamine; Dominance, Cerebral; Dop | 1998 |
Behavioral changes associated with grafts of embryonic ventral mesencephalon tissue into the striatum and/or substantia nigra in a rat model of Parkinson's Disease.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain Tissue Transplantation; Corpus Striatum; Dext | 1999 |
A new putative neuroregulator of the extrapyramidal system.
Topics: Animals; Dextroamphetamine; Extrapyramidal Tracts; Haloperidol; Humans; Male; Methyltyrosines; Neuro | 1978 |
Enkephalins and nigrostriatal function.
Topics: Animals; Apomorphine; Behavior, Animal; Dextroamphetamine; Endorphins; Enkephalins; Hydroxydopamines | 1978 |
Hemiparkinsonism. A human model for studying dopaminergic supersensitivity.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Dextroamphetamine; Disease Models, Animal; | 1979 |
Movement disorders secondary to drugs.
Topics: Age Factors; Dextroamphetamine; Humans; Metals; Movement Disorders; Myoclonus; Parkinson Disease, Se | 1973 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine | 1968 |